CorAct Advanced Technologies Ltd.

Presentation Time and Location
on 25th, during Rising Israeli Stars Session (from 15.40 to 16.15}
Company Website
http://www.cor-act.com/
Company Profile

Cor-Act Advanced Technologies, developing a life supporting system, for patients dying from chronic heart failure). Cor-Act will shortly launch the first fully implantable, Cardiac Assist Device with no blood contact. Our solution is designed as a cost- effective technology to solve the growing gap between of patients waiting for a transplant / mechanical support and the actual expensive available therapies. The Cor-Act’s Cardiac Assist Device system incorporates a miniaturized implantable pump connected to silicone elements which are pressing the myocardium.

Eidit Toren
Eidit Toren
CEO 
Conference attendance

CytoReason

Presentation Time and Location
on 25th, during Rising Israeli Stars Session (from 15.40 to 16.15)
Company Website
www.cytoreason.com
Company Profile

CytoReason is a big-data analytics company specializing in immunotherapy using its proprietary Cell-Centered Model. The proprietary machine-learning engine enhances its performance with each new dataset introduced, leveraging hundreds of published and unpublished immunotherapy datasets. Its prior knowledge allows for ever-improving accuracy, translating high-resolution measurements to specific immune-cellular interactions that extend beyond the data provided by the customer and can be translated to valuable IP. CytoReason’s technology has yielded 2 pending patents, 7 scientific collaborations and 12 peer reviewed publications

Company Type
Other Sector
Immunology
Keywords

immuno-oncology

inflammatory diseases

inflammatory autoimmune 

big data

biomarker

Year Founded
2016
Pipeline Product 1: Name/Stage
proprietary Cell-Centered Model
Product 1: Description

Our technology integrates different genomic and proteomic measurements with clinical data and predicts cellular immunological pathways.

The proprietary machine-learning engine enhances its performance with each new dataset introduced, leveraging hundreds of published and unpublished immunotherapy trials. Its prior knowledge allows for ever-improving accuracy, translating high-resolution measurements to specific immune-cellular interactions. The system generates immune interaction networks that extend beyond the data provided by the customer.  

CytoReason is generating valuable IP and Know-How for biotech and pharmaceutical companies, universities and research institutions throughout their basic research, drug development, and clinical trials. 

Investment and Licensing (In/Out) Opportunity 1: Name
collaboration
Dr Orit Shaked
Dr Orit Shaked
BD 
Conference attendance
Biography

Experienced Vice President Of Business Development with a demonstrated history of working in the pharmaceuticals industry. Skilled in Medical Devices, Biotechnology, Fundraising, Biomedical Engineering, and Start-ups. Strong sales professional 

David Harel
President 
Conference attendance